You are here: Industry Insights > Univercells Technologies

News List

Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production PharmaSources
July 07, 2021
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a worldwide strategic partnership with VectorBuilder, a global leader in vector design, optimization and manufacturin
Univercells Technologies Collaborates with NIBRT contractpharma
May 20, 2021
Univercells Technologies, a global provider of next-generation biomanufacturing technologies, and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland, are collaborating to address the need for training in cell and ...
Univercells, Univercells Technologies and Gamma Biosciences announce Mathias Garny as new CEO of Univercells Technologies PharmaSources.com
March 16, 2021
Univercells S.A., Univercells Technologies, and Gamma Biosciences are pleased to announce that effective March 15, 2021, Mathias Garny has been appointed as the Chief Executive Officer of Univercells Technologies, a Univercells company and global ...
High Purity New England Unveils Highly Scalable Intensified & Integrated Upstream Solutions from Univercells Technologies PharmaSources.com
March 10, 2021
High Purity New England (HPNE), a leading supplier of solutions for the biopharma industry, has officially introduced a new line of fixed-bed, single-use bioreactors from Univercells Technologies for the US Market.
Univercells Technologies introduces the NevoLine™ Upstream Platform for intensified & automated virus manufacturing Univercells Technologies
September 17, 2020
Univercells Technologies has introduced a new platform in the NevoLine biomanufacturing product family, the NevoLine Upstream platform.
Exyte and Univercells Technologies to deploy vaccine production plants expresspharma
May 15, 2020
The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to the COVID-19 pandemic.
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants Univercells Technologies
May 14, 2020
Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.
Univercells Launches Bioprocess Technologies Subsidiary contractpharma
May 07, 2020
Will focus on the development and commercialization of intensified, automated biomanufacturing technologies.
Introducing Univercells Technologies Univercells Technologies
May 07, 2020
Univercells’ subsidiary focused on the development and commercialization of intensified, automated biomanufacturing technologies.